Please login to the form below
Darwin's Medicine blog
Professor Brian D Smith is an authority on the pharmaceutical industry and works at SDA Bocconi University and Hertfordshire Business School.
Professor Brian D Smith is an authority on the pharmaceutical industry and works at SDA Bocconi University and Hertfordshire Business School. He welcomes comments and questions on this column at brian.smith@pragmedic.com
COVID-19 Updates and Daily News
Featured jobs
-
Account Management
-
Competitive Salary Offered
-
Senior Account Executive
-
Competitive Salary
- Medical Writer, Senior Medical Writer, Principal Medical Writer,...
-
Highly Competitive Salary, Bonus &Benefits
-
Senior Medical Writer
-
Competitive Salary
- Account Manager / Senior Account Manager - Creative MedComms - C...
-
Excellent Remuneration
-
Publications Director
-
Competitive Salary
- Senior Account Director & Associate Director - Healthcare Ad...
-
Highly Competitive Salary, Bonus &Benefits
- Senior Medical Writer– Medical Education – Oxford - London
-
Excellent Remuneration Package
- Home Working Medical Copy Writer & Senior Medical Copy Write...
-
Highly Competitive Salary, Bonus &Benefits
-
Medical Editor
-
Competitive Salary
- Senior Account Manager/ Account Director
-
Competitive Salary Offered
- Account Manager - Creative Healthcare Communications - South Wes...
-
Excellent Remuneration
- Senior Account / Programme Manager - MedComms - Buckinghamshire
-
Highly Competitive Remuneration packages
- Client Services Director – London or Home Based – Medical Commun...
-
Highly Competitive Salary, Bonus &Benefits
- Senior & Principal Medical Writer
-
Competitive Salary Offered
- Medical Writers (All levels) Editorial / Scientific Leads & ...
-
Highly Competitive Remuneration packages
-
Account Manager
-
Competitive Salary
- Editor & Senior Editor - Medical Communications - Home Based
-
Highly Competitive Salary, Bonus &Benefits
-
Associate Account Director
-
Competitive Salary
- Novavax is close to finalising a COVID-19 vaccine supply deal with the EU
- CureVac outlines COVID-19 vaccine production plans ahead of regulatory approval
- GSK’s revenue drops by 18% in Q1 as performance pressures mount
- Novavax seeks FDA emergency approval for COVID-19 vaccine by May
- Pfizer CEO says oral COVID-19 pill could be ready by the end of the year
- Novartis announces delay in UK cholesterol drug study
- Deep 6 AI: the smart software breathing new life into clinical trials
- Pfizer’s COVID-19 vaccine yields $3.5bn in first quarter sales
- Oxford University Press adds new innovative ePrint options to its product portfolio for healthcare marketing and education
- BioNTech on course to produce three billion doses of Pfizer-partnered COVID-19 vaccine in 2021
- Eli Lilly/AbCellera’s COVID-19 variant-targeting antibody enters clinical trials
- COVID-proof: How Teams are Creating Launch Intensity thru Adversity
- GSK’s revenue drops by 18% in Q1 as performance pressures mount
- Pfizer CEO says oral COVID-19 pill could be ready by the end of the year
- FDA removes clinical hold on uniQure’s haemophilia gene therapy
- Pfizer acquires Amplyx Pharmaceuticals, including new potential class of therapeutics
- Live Webinar: Improving Healthcare Access & Consumer Choice Through Digital Health
- Mapping the patient journey: eight ways to improve support programmes
PMHub
certain health
Transforming the way health brands and companies communicate, we deliver creative science led, insight-driven solutions that give award winning results...
Latest intelligence
- Deep 6 AI: the smart software breathing new life into clinical trials
- Fishawack Health interviews Wout Brusselaers, the Deep 6 AI CEO using artificial intelligence to solve one of the greatest barriers stagnating healthcare innovation—clinical trial recruitment and retention....
- COVID-proof: How Teams are Creating Launch Intensity thru Adversity
- Now that the game has changed, how are marketers shifting their launch behaviour? We've identified 5 common observations from effective teams....
- 5 ways that lockdowns and restrictions could be affecting our allergies
- Over this last year, lockdowns and restrictions have led to changes in the day-to-day environments for people across the world. For Allergy Awareness week, we wanted to explore some of...
